Related Experiment Video
Updated: Feb 14, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
[Diagnostic evaluation of the developmental level in children identified at risk of delay through the Child
Antonio Rizzoli-Córdoba1, Martha Carmen Campos-Maldonado2, Víctor Hugo Vélez-Andrade2
1Unidad de Investigación en Neurodesarrollo, Hospital Infantil de México Federico Gómez, México D.F., México.
Background:
The Child Development Evaluation (or CDE Test) was developed in Mexico as a screening tool for child developmental problems. It yields three possible results: normal, slow development or risk of delay. The modified version was elaborated using the information obtained during the validation study but its properties according to the base population are not known. The objective of this work was to establish diagnostic confirmation of developmental delay in children 16- to 59-months of age previously identified as having risk of delay through the CDE Test in primary care facilities.
Methods:
A population-based cross-sectional study was conducted in one Mexican state. CDE test was administered to 11,455 children 16- to 59-months of age from December/2013 to March/2014. The eligible population represented the 6.2% of the children (n=714) who were identified at risk of delay through the CDE Test. For inclusion in the study, a block randomization stratified by sex and age group was performed. Each participant included in the study had a diagnostic evaluation using the Battelle Development Inventory, 2nd edition.
Results:
From the 355 participants included with risk of delay, 65.9% were male and 80.2% were from rural areas; 6.5% were false positives (Total Development Quotient ˃90) and 6.8% did not have any domain with delay (Domain Developmental Quotient <80). The proportion of delay for each domain was as follows: communication 82.5%; cognitive 80.8%; social-personal 33.8%; motor 55.5%; and adaptive 41.7%. There were significant differences in the percentages of delay both by age and by domain/subdomain evaluated.
Conclusions:
In 93.2% of the participants, developmental delay was corroborated in at least one domain evaluated.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Self-Evaluation: Self-Enhancement and Self-Verification
Nursing Evaluation
Self-Evaluation Maintenance Model

